Molecular Partners AG American Depositary Shares
Symbol: MOLN (NASDAQ)
3.72
▼ (-0.80%) -0.030
Company Description:
Molecular Partners AG is a clinical stage biopharmaceutical company. The Company has programs in various stages of pre-clinical and clinical development, with oncology as its main focus. The firm develops protein therapeutics called DARPin therapeutics for the treatment of serious diseases, including cancer and sight-threatening disorders. The company's product pipeline is organized principally through three areas: Ophthalmology, including the creation of therapies for retinal diseases like wet age-related macular degeneration and diabetic macular edema; the Oncology pipeline comprises DARPin candidates with novel modes of action, including multi-DARPin compounds; and Immuno-oncology for anticancer treatment.
Key Stats
- Today's Open: $3.73
- Today's High: $3.79
- Today's Low: $3.67
- Today's Volume: 2.29K
- Yesterday Close: $3.75
- Yesterday High: $3.76
- Yesterday Low: $3.71
- Yesterday Volume: 1.64K
- Last Min Volume: 4
- Last Min High: $3.72
- Last Min Low: $3.72
- Last Min VWAP: $3.72
Company Profile
- Name: Molecular Partners AG American Depositary Shares
- Website: https://www.molecularpartners.com
- Listed Date: 2021-06-16
- Location: ,
- Market Status: Active
- CIK Number: 0001745114
- SIC Code:
- SIC description:
- Market Cap: $140.22M
- Round Lot: 100
- Outstanding Shares: 37.39M
- Asset Type: ADRC
RECENT FILINGS FOR MOLN
| Filing Date | Filing Type | Format |
|---|---|---|
| 2025-08-25 | 6-K | View |
| 2025-07-17 | SCHEDULE 13G | View |
| 2025-06-25 | S-8 | View |
| 2025-06-12 | 6-K | View |
| 2025-05-15 | 6-K | View |
| 2025-05-02 | SCHEDULE 13G | View |
| 2025-04-29 | 6-K | View |
| 2025-04-24 | EFFECT | View |
| 2025-04-22 | CORRESP | View |
| 2025-04-21 | UPLOAD | View |
| 2025-04-11 | F-3 | View |
| 2025-03-06 | 6-K | View |
| 2025-03-06 | 6-K | View |
| 2025-03-06 | 20-F | View |
| 2025-01-13 | 6-K | View |
| 2025-01-13 | 6-K | View |
| 2024-10-31 | 6-K | View |
| 2024-10-29 | SC 13D/A | View |
| 2024-10-28 | 6-K | View |
| 2024-10-25 | 424B5 | View |
Latest News on MOLN